View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Dassault Systèmes

Tackling CMC Authoring Challenges

White Paper

Tackling CMC Authoring Challenges

By Dassault Systèmes

Tackling CMC Authoring Challenges

By Dassault Systèmes
Enter your details to receive the free white paper:

Authoring Chemistry, Manufacturing and Controls (CMC) dossiers is a complex process. Information is collected from the early development to the approval of the Marketing Authorization and beyond once the product is commercialized.

Before a medicinal product can reach the wider population of patients, clinical studies take place. This will ensure the safety and efficacy of a product for its intended use. A product used in humans is subject to high scrutiny from the Health Authorities and clinical studies are closely supervised. Biopharmaceutical companies need to provide precise information on the quality of the product. For example: how and where is the drug made, what kind of materials are used and how are they tested, how can the methods used to test the raw materials assure product consistency and quality, how long can the product be used, how have the specific quality attributes been identified and how they are controlled and monitored.

Download the white paper to learn more.

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.